Ohio State is in the process of revising websites and program materials to accurately reflect compliance with the law. While this work occurs, language referencing protected class status or other activities prohibited by Ohio Senate Bill 1 may still appear in some places. However, all programs and activities are being administered in compliance with federal and state law.

Relevant Funding Opportunities

NSF Dear Colleague Letter: Posttranscriptional and Posttranslational Modification (PPM) - No Deadline

NAS Report “Charting a Future for sequencing RNA and its modifications”
https://nap.nationalacademies.org/read/27165/chapter/1

RFA-CA-24-029 RNA Modifications Driving Oncogenesis
Posted Date: July 29, 2024
Open Date (Earliest Submission Date): October 04, 2024
Letter of Intent Due Date(s): October 05, 2024
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-029.html

RFA-AG-25-023 Deciphering the Impact of RNA Modifications on Brain Aging and AD/ADRD
Posted Date: July 31, 2024
Open Date (Earliest Submission Date): October 01, 2024
Letter of Intent Due Date(s): October 01, 2024
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-029.html

Notice of Pre-Application Webinar for RFA-CA-24-029, "RNA Modifications Driving Oncogenesis (RNAMoDO; U01 Clinical Trial Not Allowed)" Program
(NOT-CA-24-101)
National Cancer Institute

Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed)
(RFA-AI-24-057)
National Institute of Allergy and Infectious Diseases

Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed)
(RFA-AI-24-064)
National Institute of Allergy and Infectious Diseases